A serial entrepreneur having begun a career in the Life Sciences team at PA Consulting group followed by co-founding two companies in the information technology and life sciences sector. The second of these companies, Oxygen Healthcare Ltd was acquired by Piramal Enterprises Ltd (BSE: PEL). Sunil is the Chairman of Exonate and a board member of Cambridge Angels, Biotech Industry Association, and advisory board of the DBT & CRUK affordable cancer medicines initiative. Sunil has a degree in Biochemistry from Keele and an MBA from Cambridge University.

A serial entrepreneur having begun a career with the Strategy group of at Accenture followed by co-founding two companies in the technology and life sciences sector. The second of these companies focused on drug discovery was acquired by a public company. Prashant co-founded o2h Ventures which is involved in seeding, incubating and investing in early stage life science and technology companies. Prashant has a BEng, MSc and an MPhil in Management.

Creative and innovative medicinal chemist with extensive knowledge and expertise. Twenty five years experience working in the pharmaceutical industry.

Gayathri leads the biology capabilities in Ahmedabad, India and Cambridge, UK. She also significantly contributes to the business development with the o2h customers world-wide, understanding the market requirements, contributing to technology transfer and investment evaluations. Prior to this, she has worked for >15 years in different therapeutic areas in both industry and academia. She has led multiple programs in drug discovery projects through lead optimization to candidate selection and further development to late stage clinical trials. She has worked in a multi-disciplinary environment, leading chemical biology efforts creating chemical tools that modulate novel class of “undruggable” targets. Gayathri has a Ph.D. in Neuroscience from the Brain Research Institute, Zurich, Switzerland.

Claudio got his PhD in Chemistry (Mechanisms of Organic Reactions) from the University in 2000. He went for a post-doc at Imperial College London where he worked on Alzheimer's disease chemical probes. In 2004, he started working in several companies in the Cambridge biotech cluster where he deepened his knowledge in Medicinal Chemistry and in Fragment Based Drug Design. In 2012 he went back to academia at Cambridge University where he investigated challenging drug targets such as protein-protein interactions. He also co-founded the Entrepreneurial Postdocs of Cambridge (EPOC) society in 2015 to support postdocs in their pursuit of entrepreneurial careers. In 2017 joined Capital Cell and then Abzena in Cambridge with a role in Business Development.

Comprehensive experience in Leading & Guiding Multi-FTE “Synthetic Chemistry Research” Collaborations which are in support to fast paced Medicinal Chemistry Projects – for overseas collaborators.

Dharmesh obtained his Master’s degree in Chemistry from M.K University and has done MBA in industrial Management from National Institute of Management. He has about 27 years of industrial experience during which he has served many MNCs like Zydus Cadila, Piramal, Dishman Pharma, Daicel etc. He was associated with O2h in 2006 and worked for 3 years and moved to another organization. He re-joined the o2h family back in April-2023. During his professional tenure, Dharmesh has led the Analytical team which includes chromatography and spectroscopy group. He has immense expertise in the purification, isolation & characterization of heterocyclic, macrocyclic, natural products, etc. Dharmesh was also in role of Sales & BD for analytical services, pharma impurity standard, separation services & column business for domestic market. He has been for several years leading a big team of Analytical chemists (currently ~80) who skilfully operate instruments like LCMS, HPLC, SFC, NMR, and Preparative HPLC under his guidance.